-
-
-
-
-
-
-
Trevi Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Updates
-
-
-
-
-
-
-
Trevi Therapeutics (TRVI) Announces Additional Analyses from Phase 2a RIVER Trial of Haduvio in Patients with Refractory Chronic Cough
-
-
-
-
-
-
-
Trevi Therapeutics Reports Fourth Quarter and Year End 2024 Financial Results and Provides Business Updates
-
-
-
-
-
-
-
Trevi Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Updates
-
-
-
-
-
-
-
Trevi Therapeutics to Report Second Quarter 2024 Financial Results and Provide a Corporate Update on August 8, 2024
-
-
-
-
-
-
-
Trevi Therapeutics Reports Fourth Quarter and Year End 2023 Financial Results and Provides Business Updates
-
-
-
-
-
-
-
Trevi Therapeutics to Report Q3 2023 Financial Results and Provide a Corporate Update on November 9, 2023
-
1,168,522 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

